| Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies LI Kozlovskaya, AN Piniaeva, GM Ignatyev, IV Gordeychuk, VP Volok, ... Emerging microbes & infections 10 (1), 1790-1806, 2021 | 75 | 2021 |
| Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak L Kozlovskaya, A Piniaeva, G Ignatyev, A Selivanov, A Shishova, ... International Journal of Infectious Diseases 99, 40-46, 2020 | 54 | 2020 |
| Impact of universal hepatitis B vaccination on prevalence, infection-associated morbidity and mortality, and circulation of immune escape variants in Russia VV Klushkina, KK Kyuregyan, TV Kozhanova, OE Popova, PG Dubrovina, ... PLoS One 11 (6), e0157161, 2016 | 42 | 2016 |
| HIV-1 reverse transcriptase promotes tumor growth and metastasis formation via ROS-dependent upregulation of twist E Bayurova, J Jansons, D Skrastina, O Smirnova, D Mezale, ... Oxidative Medicine and Cellular Longevity 2019, 2019 | 27 | 2019 |
| Проблемы скрытой инфекции, вызванной вирусом гепатита В ИА Морозов, ЛЮ Ильченко, НИ Громова, ИГ Фёдоров, ИВ Гордейчук, ... Рос. журн. гастроэнтерол., гепатол., колопроктол 22 (4), 58-66, 2012 | 27 | 2012 |
| Therapeutic vaccines against human papilloma viruses: achievements and prospects MS Vonsky, AL Runov, IV Gordeychuk, MG Isaguliants Biochemistry (Moscow) 84, 800-816, 2019 | 25 | 2019 |
| A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV AV Kovyrshina, IV Dolzhikova, DM Grousova, MV Balyasin, AG Botikov, ... Immunology 41 (2), 135-143, 2020 | 22* | 2020 |
| DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response S Petkov, E Starodubova, A Latanova, A Kilpeläinen, O Latyshev, ... PLoS One 13 (6), e0197902, 2018 | 22 | 2018 |
| The evaluation of pharmacodynamics and pharmacokinetics of anti-thrombin DNA aptamer RA-36 E Zavyalova, N Samoylenkova, A Revishchin, A Turashev, I Gordeychuk, ... Frontiers in Pharmacology 8, 922, 2017 | 22 | 2017 |
| Групповая заболеваемость гепатитом Е в г. Коврове Владимирской области (Предварительное сообщение) МИ Михайлов, ЕЮ Малинникова, КК Кюрегян, ОЕ Исаева, ... Труды Института полиомиелита и вирусных энцефалитов имени МП Чумакова РАМН …, 2009 | 22 | 2009 |
| Vaccination with oral polio vaccine reduces COVID-19 incidence NV Yagovkina, LM Zheleznov, KA Subbotina, AA Tsaan, LI Kozlovskaya, ... Frontiers in Immunology 13, 907341, 2022 | 21 | 2022 |
| Серологические маркеры инфицирования вирусами гепатитов среди условно здорового населения Республики Тыва ТВ Кожанова, ЛЮ Ильченко, ВВ Клушкина, ВС Кичатова, НВ Соболева, ... Труды Института полиомиелита и вирусных энцефалитов имени МП Чумакова РАМН …, 2013 | 20* | 2013 |
| ATM and ATR expression potentiates HBV replication and contributes to reactivation of HBV infection upon DNA damage A Kostyusheva, S Brezgin, E Bayurova, I Gordeychuk, M Isaguliants, ... Viruses 11 (11), 997, 2019 | 18 | 2019 |
| Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts IV Gordeychuk, LI Kozlovskaya, AA Siniugina, NV Yagovkina, VI Kuzubov, ... Viruses 15 (9), 1828, 2023 | 14* | 2023 |
| Replenishment of hepatitis B virus cccDNA pool is restricted by baseline expression of host restriction factors in vitro S Brezgin, A Kostyusheva, E Bayurova, I Gordeychuk, M Isaguliants, ... Microorganisms 7 (11), 533, 2019 | 14 | 2019 |
| Immunity and viral infections: modulating antiviral response via CRISPR–Cas systems S Brezgin, A Kostyusheva, E Bayurova, E Volchkova, V Gegechkori, ... Viruses 13 (7), 1373, 2021 | 13 | 2021 |
| Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates AI Tukhvatulin, IV Gordeychuk, IV Dolzhikova, AS Dzharullaeva, ... Emerging Microbes & Infections 11 (1), 2229-2247, 2022 | 12 | 2022 |
| Оценка иммунологической эффективности массовой вакцинации против гепатита В ТВ Кожанова, ВВ Клушкина, ИВ Гордейчук, КК Кюрегян, МИ Михайлов Труды Института полиомиелита и вирусных энцефалитов имени МП Чумакова РАМН …, 2014 | 11 | 2014 |
| Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9 D Kostyushev, A Kostyusheva, S Brezgin, N Ponomareva, NF Zakirova, ... Molecular Therapy-Nucleic Acids 31, 482-493, 2023 | 8 | 2023 |
| Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the Middle East respiratory syndrome DM Grousova, OV Zubkova, AI Tukhvatulin, AV Kovyrshina, NL Lubenets, ... Acta Naturae (англоязычная версия) 12 (3 (46)), 114-123, 2020 | 8* | 2020 |
Ekaterina BayurovaChumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products oVerified email at chumakovs.su
